DE68926269T2 - Dermorphin-Analoge, deren Herstellungsverfahren, pharmazeutische Zusammensetzungen und Methode zur therapeutischen Behandlung unter Verwendung der Analoge - Google Patents

Dermorphin-Analoge, deren Herstellungsverfahren, pharmazeutische Zusammensetzungen und Methode zur therapeutischen Behandlung unter Verwendung der Analoge

Info

Publication number
DE68926269T2
DE68926269T2 DE68926269T DE68926269T DE68926269T2 DE 68926269 T2 DE68926269 T2 DE 68926269T2 DE 68926269 T DE68926269 T DE 68926269T DE 68926269 T DE68926269 T DE 68926269T DE 68926269 T2 DE68926269 T2 DE 68926269T2
Authority
DE
Germany
Prior art keywords
analogs
pharmaceutical compositions
manufacturing process
therapeutic treatment
dermorphin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE68926269T
Other languages
English (en)
Other versions
DE68926269D1 (de
Inventor
Peter W Schiller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
Astra AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra AB filed Critical Astra AB
Application granted granted Critical
Publication of DE68926269D1 publication Critical patent/DE68926269D1/de
Publication of DE68926269T2 publication Critical patent/DE68926269T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
DE68926269T 1988-06-30 1989-06-30 Dermorphin-Analoge, deren Herstellungsverfahren, pharmazeutische Zusammensetzungen und Methode zur therapeutischen Behandlung unter Verwendung der Analoge Expired - Fee Related DE68926269T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA570874 1988-06-30

Publications (2)

Publication Number Publication Date
DE68926269D1 DE68926269D1 (de) 1996-05-23
DE68926269T2 true DE68926269T2 (de) 1996-08-14

Family

ID=4138301

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68926269T Expired - Fee Related DE68926269T2 (de) 1988-06-30 1989-06-30 Dermorphin-Analoge, deren Herstellungsverfahren, pharmazeutische Zusammensetzungen und Methode zur therapeutischen Behandlung unter Verwendung der Analoge

Country Status (8)

Country Link
US (1) US5312899A (de)
EP (1) EP0350221B1 (de)
AT (1) ATE136905T1 (de)
DE (1) DE68926269T2 (de)
ES (1) ES2085865T3 (de)
GR (1) GR3020139T3 (de)
HK (1) HK22797A (de)
SG (1) SG64368A1 (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5602100A (en) * 1988-06-30 1997-02-11 Astra Ab Dermorphin analogs having pharmacological activity
JPH09505555A (ja) * 1993-08-13 1997-06-03 ザ ガバメント オブ ザ ユナイテッド ステイツ オブ アメリカ，アズ リプレゼンテッド バイ ザ セクレタリー，デパートメント オブ ヘルス アンド ヒューマン サービシーズ ＴＧＦ−βの活性を刺激および阻害する方法および組成物
SE9503924D0 (sv) * 1995-08-18 1995-11-07 Astra Ab Novel opioid peptides
US5962477A (en) 1994-04-12 1999-10-05 Adolor Corporation Screening methods for cytokine inhibitors
US6190691B1 (en) 1994-04-12 2001-02-20 Adolor Corporation Methods for treating inflammatory conditions
US6184208B1 (en) 1994-06-29 2001-02-06 Immunotech Developments Inc. Peptide, a method for its preparation and a pharmaceutical composition containing the peptide
US6573282B1 (en) 1995-09-12 2003-06-03 Adolor Corporation Peripherally active anti-hyperalgesic opiates
US5849761A (en) * 1995-09-12 1998-12-15 Regents Of The University Of California Peripherally active anti-hyperalgesic opiates
US5885958A (en) 1997-03-25 1999-03-23 Administrators Of The Tulane Educational Fund Mu-opiate receptor peptides
US20030158220A1 (en) * 1997-11-03 2003-08-21 Foss Joseph F. Use of methylnaltrexone and related compounds to treat chronic opioid use side effects
SE9900961D0 (sv) * 1999-03-16 1999-03-16 Astra Ab Novel compounds
DE60143945D1 (de) * 2000-07-18 2011-03-10 Cornell Res Foundation Inc Medizinische verwendung von agonisten des mu-opioid rezeptors
US7316819B2 (en) 2001-03-08 2008-01-08 Unigene Laboratories, Inc. Oral peptide pharmaceutical dosage form and method of production
US7401046B2 (en) * 2001-07-25 2008-07-15 Chicago Board Options Exchange System and method for displaying option market information
US8088734B2 (en) 2003-01-21 2012-01-03 Unigene Laboratories Inc. Oral delivery of peptides
EP2491943B1 (de) 2003-02-04 2018-10-10 Cornell Research Foundation, Inc. Verfahren zum Verhindern des Übergangs der Mitochondrienpermeabilität
CN104383542B (zh) 2003-04-08 2017-09-26 普罗热尼奇制药公司 包含甲基纳曲酮的药物配方
CA2524258C (en) 2003-05-01 2012-08-07 Cornell Research Foundation, Inc. Carrier complexes comprising cationic peptides for delivering molecules to cells
US20050215476A1 (en) * 2004-01-21 2005-09-29 Unigene Laboratories Inc. Amidated parathyroid hormone fragments and uses thereof
JP4931604B2 (ja) * 2004-01-23 2012-05-16 コーネル リサーチ ファウンデイション インコーポレイテッド 酸化的損傷を低減する方法
US20050282756A1 (en) 2004-06-18 2005-12-22 Mehta Nozer M Oral delivery of peptide pharmaceutical compositions
AR057325A1 (es) * 2005-05-25 2007-11-28 Progenics Pharm Inc Sintesis de (s)-n-metilnaltrexona, composiciones farmaceuticas y usos
AR057035A1 (es) * 2005-05-25 2007-11-14 Progenics Pharm Inc SíNTESIS DE (R)-N-METILNALTREXONA, COMPOSICIONES FARMACÉUTICAS Y USOS
CA2947335A1 (en) 2005-09-16 2007-03-29 Cornell Research Foundation, Inc. Methods for reducing cd36 expression
JP2009531335A (ja) * 2006-03-30 2009-09-03 サルペップ バイオテクノロジー インコーポレイテッド 神経障害性疼痛の抑制および治療
TW200817048A (en) * 2006-09-08 2008-04-16 Wyeth Corp Dry powder compound formulations and uses thereof
MX2009010552A (es) 2007-03-29 2009-12-14 Progenics Pharm Inc Antagonistas de receptor de opioide periferico y usos de los mismos.
AU2008233133B2 (en) 2007-03-29 2014-03-27 Progenics Pharmaceuticals, Inc. Crystal forms of (R) -N-methylnaltrexone bromide and uses thereof
MX2009010515A (es) 2007-03-29 2009-10-19 Wyeth Corp Antagonistas del receptor opioide periferico y usos de los mismos.
KR101581480B1 (ko) * 2008-02-06 2015-12-30 프로제닉스 파머슈티컬스, 인코포레이티드 (ｒ),(ｒ)-2,2'-비스-메틸날트렉손의 제조법 및 용도
CA2713150C (en) 2008-02-07 2016-01-05 Cornell University Methods for preventing or treating insulin resistance
CN106975070A (zh) 2008-02-26 2017-07-25 康奈尔大学 用于防止和治疗急性肾损伤的方法
CA2676881C (en) 2008-09-30 2017-04-25 Wyeth Peripheral opioid receptor antagonists and uses thereof
CN103933542A (zh) 2009-03-20 2014-07-23 通用医疗公司以马萨诸塞州通用医疗公司名义经营 预防和治疗烧伤损伤和继发性并发症的方法
JP5909182B2 (ja) * 2009-08-12 2016-04-26 コーネル ユニヴァーシティー 代謝性症候群を予防し又は治療するための方法
EP3318264A1 (de) 2009-08-24 2018-05-09 Stealth Peptides International, Inc. Verfahren und zusammensetzungen zur prävention oder behandlung ophthalmischer leiden
EP2944317A1 (de) * 2009-10-05 2015-11-18 Cornell University Verfahren zur Prävention und Behandlung von Herzinsuffizienz
JP6157481B2 (ja) 2011-09-29 2017-07-05 メイヨ ファンデーション フォア メディカル エディケイション アンド リサーチ 芳香族陽イオン性ペプチドおよびその使用方法
WO2017156403A1 (en) * 2016-03-11 2017-09-14 Stealth Biotherapeutics Crystalline salt forms
EP3606938A1 (de) 2017-04-05 2020-02-12 Stealth BioTherapeutics Corp Kristalline salzformen von boc-d-arg-dmt-lys-(boc)-phe-nh2
US10278957B2 (en) 2017-09-11 2019-05-07 Protagonist Therapeutics, Inc. Opioid agonist peptides and uses thereof
PL439243A1 (pl) * 2021-10-18 2023-04-24 Instytut Medycyny Doświadczalnej I Klinicznej Im. Mirosława Mossakowskiego Polskiej Akademii Nauk Nowy analog dermorfiny jako lek przeciwbólowy do stosowania w leczeniu bólu przewlekłego

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8005121A (nl) * 1979-09-20 1981-03-24 Erba Farmitalia Biologisch actieve peptiden.
HU185263B (en) * 1981-06-12 1984-12-28 Richter Gedeon Vegyeszet Process for producing peptides effective on the immuncontroll analogous with the tp5
DE3435727A1 (de) * 1984-09-28 1986-04-10 Victor Dipl.-Chem. Dr.med. 6200 Wiesbaden Brantl Pharmakologisch aktive peptide

Also Published As

Publication number Publication date
EP0350221A2 (de) 1990-01-10
SG64368A1 (en) 1999-04-27
ATE136905T1 (de) 1996-05-15
EP0350221B1 (de) 1996-04-17
GR3020139T3 (en) 1996-08-31
EP0350221A3 (en) 1990-09-12
ES2085865T3 (es) 1996-06-16
DE68926269D1 (de) 1996-05-23
HK22797A (en) 1997-02-27
US5312899A (en) 1994-05-17

Similar Documents

Publication Publication Date Title
DE68926269T2 (de) Dermorphin-Analoge, deren Herstellungsverfahren, pharmazeutische Zusammensetzungen und Methode zur therapeutischen Behandlung unter Verwendung der Analoge
HUT58036A (en) Process for producing new substituted aminomethyl tetraline derivatives and their heterocyclic analogs, as well as pharmaceutical compositions comprising such compounds
HUT49113A (en) Process for producing 2-/2-hydroxy-3-phenoxy-propyl-amino/-ethyl-phenoxy-methyl-amido derivatives and pharmaceutical compositions containing them as active components
SE8305535L (sv) Lekemedelspreparat med antinikotinverkan och forfarande for framstellning derav
ZA918734B (en) Cyclic imino derivatives, pharmaceutical compositions containing these compounds and processes for preparing them.
HU905333D0 (en) Process for producing cyclic amino-acid derivatives
UA27749C2 (uk) Заміщені циклопропіламіно-1,3,5-триазини, їх оптичні ізомери, рацемічні суміші чи їх солі приєднання нетоксичних фармацевтично прийнятних кислот, що мають фармакологічну активність, спосіб їх одержання (варіанти) та фармацевтична композиція на їх основі
ATE65402T1 (de) Ifosfamid-mesna-lyophilisat und verfahren zu dessen herstellung.
DK217588A (da) 17beta-(cyclopropylamino)-androst-5-en-3beta-olderivater, deres fremstilling og anvendelse som laegemidler
NO303715B1 (no) Stabilt, vandig apparat
ES8609312A1 (es) Procedimiento para la preparacion de silibinina exenta de isosilibina
HUT55034A (en) Process for producing peptides with hemoregulating effect and pharmaceutical compositions comprising such compounds as active ingredient
DE3764235D1 (de) Ifosfamid-lyophilisat und verfahren zu dessen herstellung.
IE892094L (en) New strontium salt, process for the preparation thereof and¹pharmaceutical compositions containing it
ZA875640B (en) 2-acyloxypropylamine derivatives,process for the preparation thereof and pharmaceutical compositions containing them
DE69810340D1 (de) Naphtho-imidazo(1,2-a)pyridin derivate, deren herstellung und deren verwendung in der behandlung von störungen des zentralnervensystems
ATE40687T1 (de) Neue pyridinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
MX9600165A (es) 3-alcoxicarbonil-tiadiazinonas, proceso para su preparacion y composiciones farmaceuticas que las contienen.
DK632187A (da) Ny forbedret fremgangsmaade til fremstilling af penicillansyrederivater
ES540982A0 (es) Un procedimiento para la preparacion de cis-3,3,5-trimetil- ciclohexil-d,l-alda-(3-piridincarboxi)-fenilacetato
NO163283C (no) Analogifremgangsm te til fremstilling av terapeutisk aktive n-bicykloheptyl og n-bicykloheptenylimidazoler.
SE8005309L (sv) Nya 5alfa-pregnan-20-ol-derivat och salter derav med syror, sett for framstellning samt anvendning derav sasom lekemedel samt kompositioner innehallande dessa foreningar
HU902502D0 (en) Process for producing pharmacologically active compounds and therapeutical preparatives containing these compounds
ATE10934T1 (de) Peptid, verfahren zu dessen herstellung und dessen verwendung.
HU904983D0 (en) Process for producing imidazo(5,1-b)quinazoline-9-one derivatives and their pharmaceutically acceptible salts as well as process for producing pharmaceutical preparatives containing these active substances

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee